Rubric Capital Management LP 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Rubric Capital Management LP | 10,966,672 9.380% |
4,322,142 (+65.05%) |
Filing |
| 2024-02-12 06:06 am Purchase |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Rubric Capital Management LP | 6,644,530 7.040% |
6,644,530 (New Position) |
Filing |